A novel quinazolinone derivative induces cytochrome c interdependent apoptosis and autophagy in human leukemia MOLT-4 cells  by Kumar, Suresh et al.
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Crosstalk  between  apoptosis  and  autophagy  is budding  as one  of  the  novel  strate-
gies  in  the  cancer  therapeutics.  The  present  study  tinted  toward  the  interdependence
of  autophagy  and  apoptosis  induce  by a novel  quinazolinone  derivative  2,3-dihydro-2-
(quinoline-5-yl)  quinazolin-4(1H)-one  structure  [DQQ]  in human  leukemia  MOLT-4  cells.
DQQ induces  cytochrome  c arbitrated  apoptosis  and  autophagy  in  MOLT-4  cells.  Apopto-
sis  induces  by  DQQ  was  conﬁrmed  through  a battery  of  assay  e.g. cellular  and  nuclear
microscopy,  annexin-V  assay,  cell  cycle  analysis,  loss  of  mitochondrial  membrane  poten-
tial and  immune-expression  of cytochrome  c, caspases  and  PARP.  Furthermore,  acridine
orange  staining,  LC3  immunoﬂuorescence  and  western  blotting  of key  autophagy  pro-
teins revealed  the  autophagic  potential  of  DQQ.  A  universal  caspase  inhibitor,  Z-VAD-FMK
and  cytochrome  c  silencing,  strongly  inhibited  the  DQQ  induce  autophagy  and  apopto-
sis.  Beclin1  silencing  through  siRNA  partially  reversed  the  cell death,  which  was not as
signiﬁcant  as  by cytochrome  c  silencing.  Although,  it partially  reversed  the PARP  cleav-
age  induced  by  DQQ,  indicating  the  role  of  autophagy  in  the  regulation  of  apoptosis.  The
present  study  ﬁrst time  portrays  the  negative  feedback  potential  of cytochrome  c regulated
autophagy  and  the importance  of  quinazolinone  derivative  in discovery  of  novel  anticancer
therapeutics.
© 2014  The  Authors.  Published  by  Elsevier  Ireland  Ltd. This  is  an  open  access  article  underthe CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/3.0/).Abbreviations: AO, acridine orange; ATG, autophagy related gene; LC3, micr
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1. Introduction
Cancer is the leading cause of death in the developed as
well  as developing world and it is one of the most threaten-
ing  health disorders worldwide. An estimate of 7.6 million
deaths  was caused due to cancer worldwide accounting
13% of total deaths in 2008 and leukemia is one of the lead-
ing  causes of cancer deaths among the young males [1,2].
According to the latest report, there is a signiﬁcant decline
in  mortality induce by leukemia over past 10 years and
despite of signiﬁcant turn down in death rates, leukemia
still is a big problem [1]. Therefore, there is an unmet
need to discover and develop novel anticancer agents. In
this  regard, we have testiﬁed autophagic and apoptotic
potential of a novel quinazolinone derivative, 2,3-dihydro-
2-(quinoline-5-yl) quinazolin-4(1H)-one [DQQ] in human
leukemia MOLT-4 cells. Quinazolinone ring, a well known
structural element of many natural products and synthetic
agents, have been established as a useful privileged scaf-
fold  for library design and drug discovery applications
[3]. These compounds do not only have a wide applica-
tion as organic congeners, but have remarkable biological
and  pharmacological activities [4,5]. Many quinazolines
have been approved by FDA for different diseases such as
prazosin  used to treat high blood pressure, geﬁtinib and
erlotininib are tyrosine kinase inhibitors that speciﬁcally
target EGFR and are used to treat non small cell lung cancer,
pancreatic cancer and several other types of cancers [5]. In
addition,  2,3-dihydroquinazolinones have proven to act as
potent  tubulin inhibitors with impressive anti proliferative
activity against several human cancer cell lines. Although
different derivatives of quinazolinone have been reported
for  their anticancer activities in different cancers, but there
was  no report against any type of leukemia. Therefore, we
have  for the ﬁrst time evaluated DQQ anticancer potential
in  human leukemia cells and explore its autophagic and
apoptotic potential.
Apoptosis and autophagy are type one and two pro-
grammed cell death, respectively. They have a complex
relation with each other. Several chemotherapeutic agents
induce  autophagy and apoptosis, which is a hallmark of
all  cancers. Many studies suggested autophagy as survival
phenomenon and have reported to inhibit the process
of  apoptosis [6,7], on the other hand, there were sev-
eral  reports which reveal that autophagy activate and
accelerate apoptosis [8,9]. Autophagy and apoptosis are
interdependent and inhibition of important autophagic
genes such as beclin-1, ATG5, ATG7 and ATG10 leads the
cell  to apoptotic cell death [10], in contrast the addi-
tion of inhibitors that block the fusion of autophagosome
with lysosomes, manifested mixed type of morphologi-
cal features of autophagy and apoptosis [6]. Caspase-3
has been found to have a role in controlling both apo-
ptosis and autophagy and its inhibition associated with
reversal of both autophagic and apoptotic cell death [11].
The  speciﬁc inhibition of the proapoptotic function of
cytochrome c, a key regulator of mitochondria-mediated
apoptosis, enhanced autophagy following chemotherapeu-
tic treatment [12]. Apoptosis and autophagy potential
of quinazolinone ring members have been investigated
in different cell lines [13,14], and in most of the casesrts 1 (2014) 1013–1025
the  autophagy induced by different quinazoline deriva-
tives  are of the protective nature [15]. Our study, for
the  ﬁrst time explore the interdependence of autophagy
and apoptosis induced by 2,3-dihydro-2-(quinoline-5-
yl)quinazolin-4(1H)-one [DQQ] and negative feedback
potential of cytochrome c regulated autophagy in human
leukemia MOLT-4 cells.
2.  Materials and methods
2.1.  Cell culture, growth conditions and treatments
Human acute lymphoblastic leukemia cells MOLT-4
and K-562 were obtained from European Collection of
Cell  Cultures (ECACC). Cells were grown in RPMI-1640
medium supplemented with 10% heat inactivated fetal
bovine  serum (FBS), penicillin (100 units/ml), streptomycin
(100 g/ml), l-glutamine (0.3 mg/ml), sodium pyruvate
(550 mg/ml), and NaHCO3 (2 mg/ml). Cells were grown in
a  CO2 incubator (Thermocon Electron Corporation, USA) at
37 ◦C in an atmosphere of 95% air and 5% CO2 with 98%
humidity. Cells treated with DQQ and other inhibitors were
dissolved  in DMSO while the untreated cells received the
vehicle  (DMSO <0.2%).
2.2.  Reagents and chemicals
RPMI-1640,  DMEM,  EMEM,  propidium iodide (PI),
3-(4,5,-dimethylthiazole-2-yl)-2,5 diphenyltetrazolium
bromide (MTT), 2,7-dichlorofuoresceine diacetate (DCFH-
DA),  MG-132, Hoechst-33258, protease inhibitor cocktail,
RNase, rhodamine-123 (Rh-123), streptomycin, fetal
bovine serum, phenyl methane sulfonyl ﬂuoride (PMSF),
l-glutamine, pyruvic acid, NAC, sMIT and bovine serum
albumin were purchased from Sigma-Aldrich (Bangalore,
India). Apoalert caspases-8 and -3 ﬂuorescent assay kits,
primary  antibodies of cytochrome c and Beclin1were
purchased from B.D Biosciences (San Jose, CA). Pan speciﬁc
caspase inhibitor Z-VAD-fmk, AnnexinV-FITC apoptosis
detection kit, primary antibodies to Bcl-2, Bax, caspase-3,
caspase-8, PARP-1, -actin and siRNA transfection reagent
were  from Santa Cruz Biotechnology (Santa Cruz, CA).
Other remaining antibodies were purchased from Cell
signaling technology (Danvers, MA). Electrophoresis
reagents, protein marker and protein estimation kit were
from  Bio-Rad Laboratories (Hercules, CA). Hyper ﬁlm
and  ECL plus reagents were purchased from Amersham
Biosciences, UK. All other bio-chemicals and reagents
used in studies were AR grade and purchased from Sigma
Aldrich, India.
2.3.  Synthesis of 2,3-dihydro-2-(quinoline-5-yl)
quinazolin-4(1H)-one (DQQ)
2,3-Dihydro-2-(quinoline-5-yl) quinazolin-4(1H)-one
(DQQ) was  synthesized as described earlier [16] (Fig. 1A).
Anthranilamide (1, 1 eq) and quinoline-4-carbaldehyde
(2, 1 eq) was  dissolved in acetonitrile (5 ml)  followed by
amberlist-15 (50 mol%). The reaction mixture was  stirred at
room  temperature, ﬁlters, concentrates and puriﬁed by col-
umn  chromatography. DQQ is a light yellow solid with 85%
yield;  mp:  253–255оC; 1H NMR  (400 MHz, DMSO-d6); ı
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Fig. 1. DQQ inhibited cell proliferation in human leukemia MOLT-4 and K562 cells. (A) Chemical structure and IUPAC name of 2,3-dihydro-2-(quinoline-
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oncentrations of DQQ for 6 h, 12 h, 24 h and 48 h. MTT  dye was added
escribed  in Section 2. Data are mean ± SD (n = 8 wells).
ppm), 9.30, (d, J = 8.4 Hz, 1H), 8.95 (s, 1H), 8.38 (s, 1H), 8.08,
m,  1H), 7.80 (m,  3H), 7.59 (m,  1H), 7.29 (t, J = 7.2 Hz, 1H)
.12  (s, 1H), 6.77 (m,  2H), 6.49 (s, 1H); 13CNMR (100 MHz,
MSO-d6); ı (ppm), 163.9, 150.2, 148.3, 148.2, 135.7,
33.3, 133.1, 130.3, 128.6, 127.4, 125.8, 120.9, 117.4, 115.0,
14.5,  79.1, 65.8; IR: (KBr-pellet) 3399. 3294, 2920, 2850,
647,  1610, 1502, 1462, 1383, 1296, 1156, 1073, 795, 762,
08  cm−1; MS  (Q-TOF): m/z 276 [M + 1]+, 298 [M + Na]+;
RMS: m/z 276.1130 calcd for C17H14N3O + H+ (276.1137).
.4. Cell proliferation assayMTT  assay was done to determine the viability of the
ells  and was done as described previously [17]. Brieﬂy,
 × 103 cells were seeded in 96 well plates and were treatedand K562 cells were seeded in 96 well plates and treated with various
ore the termination of the experiment. Cell viability was calculated as
with  different concentrations of DQQ for 48 h. 20 l of MTT
dye  (2.5 mg/ml) was  added 3 h before the termination of
the  experiment. The plates were centrifuged at 400 × g for
15  min  and formulated MTT  formazen crystals were dis-
solved  in 150 l of DMSO, absorbance was measured at
570  nm with reference wavelength 620 nm.
2.5. Phase contrast microscopy
Morphological  changes in cell were studied by phase
contrast microscopy. MOLT-4 cells were incubated in
twelve  well plates and treated with different concentration
of DQQ (2–10 M)  for 24 h, after that cells were subjected
to photography on an inverted microscope attached to the
DP-12  camera (1X70, Olympus).
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2.6. Hoechst 33258 nuclear staining
Cells were treated with different concentrations of
DQQ  (2–10 M)  for 24 h and washed twice with PBS at
400  × g for 5 min. Cells were then stained with 1 ml  of
staining solution (10 g/ml, Hoechst 33258, 0.01 M cit-
ric  acid and 0.45 M disodium phosphate containing 0.05%
Tween-20) and stained for 30 min  in the dark at room
temperature. After staining the cells were resuspended
in 50 l of mounting ﬂuid (PBS:glycerol, 1:1) and 10 l
mounting suspension was observed for nuclear morphol-
ogy  under inverted ﬂuorescence microscope using UV
excitation (Olympus 1X70, magniﬁcation 30X) [18].
2.7.  Flow cytometric analysis of apoptosis and necrosis
MOLT-4 cells (1 × 106) were treated with 2 M,  5 M
and 10 M concentrations of DQQ for 24 h. Cells were dou-
ble  stained with annexin-V/PI by using kit manufacture’s
protocol (no. sc4252, Santa Cruz Biotechnology, USA). The
cells  were scanned for ﬂuorescence intensity in FL-1 (FITC)
and  FL-2 (PI) channels. The fraction of cell populations in
different  quadrants was analyzed using quadrant statistics.
The  FACS analysis of apoptosis and necrosis was done as
described  earlier [19].
2.8.  Cell cycle analysis
Cell  cycle phase distribution was studied by propidium
iodide ﬂuorescence. MOLT-4 cells (1 × 106) were incubated
with different concentrations of DQQ (2–10 M) for 24 h.
The  cells were then washed twice with ice-cold PBS, har-
vested,  ﬁxed with ice-cold PBS in 70% ethanol and stored
at  4 ◦C overnight. After ﬁxation, these cells were incubated
with RNAse-A (0.1 mg/ml) at 37 ◦C for 90 min, stained with
propidium iodide (100 g/ml) for 30 min  on ice in dark, and
then  measured for DNA content using BD FACSCalibur ﬂow
cytometer  (Becton Dickinson, USA). Resulting DNA distri-
butions  were analyzed by Modﬁt software (Verity Software
House  Inc., Topsham, ME)  for the proportions of cells in
apoptosis, G1, S, and G2/M phases of the cell cycle [20].
2.9.  Measurement of mitochondrial membrane potential
( m)
MOLT-4  cells were seeded in 12 well plates and incu-
bated with different concentration of DQQ (2–10 M)
for  24 h. Rhodamine-123 is a ﬂuorescent probe used in
estimation of mitochondrial membrane potential (m).
Rhodamine-123 dye (200 nM)  was added 30 min  before
termination of the experiment. Cells were collected at
400  × g, washed once with PBS and mitochondrial mem-
brane potential was measured in the FL-1 channel of ﬂow
cytometer (FACS Calibur, Becton Dickinson, USA) [21].
2.10.  Caspase assayCells  were treated with indicated concentrations of DQQ
for  24 h. Cells were collected, washed with PBS twice and
lysed  in cell lysis buffer. Caspase-8 and -3 activities in therts 1 (2014) 1013–1025
cell  lysates were determined ﬂuorimetrically by using BD
ApoAlert  caspase ﬂuorescent assay kits [22].
2.11. Microscopic detection of autophagy through
acridine orange staining
Induction  of autophagy was  analyzed by staining cells
with  acridine orange as described earlier [11]. Brieﬂy,
0.5 × 106 cells were seeded in 6 well plates and treated with
the  indicated doses of DQQ for 24 h. Cells were incubated
with 1 g/ml acridine orange for 15 min  prior to the termi-
nation of the experiment and were washed with PBS before
analysis  on a ﬂuorescence microscope (Olympus 1X70).
2.12.  Immunoﬂuorescence staining with LC3 for
autophagy detection
Immunoﬂuorescence for LC3 was  done as described pre-
viously  [11]. Brieﬂy, 0.5 × 105 cells were treated with 2 M,
5  M and 10 M concentrations of DQQ for 24 h, and col-
lected at 400 g. The pellets were resuspended in incomplete
medium and were subjected to poly-l-lysine (0.01% sol,
Sigma)  coated cover slips for 10 min  at room temperature.
Poly-l-lysine was  aspirated and cover slips were allowed
to  dry completely. Cells were ﬁxed in 4% paraformaldehyde
for 15 min, washed thrice for 5 min  with PBS, permeablized
with 0.2% Triton X-100, washed again and ﬁnally blocked
with  5% goat serum albumin for 20 min. After blocking
cells were incubated with LC3B antibody for 1 h followed
by  washing with PBS and incubation with secondary anti-
body  (anti-rabbit Alexa Fluor-488) for 45 min. Cells were
washed again and incubated with DAPI (1 g/ml) for 5 min.
Autophagy/apoptosis induction was  analyzed by using ﬂu-
orescence  microscope (1X81, Olympus); photographs were
taken  by using DP-71 camera.
2.13. Preparation of cytosolic and mitochondrial lysates
MOLT-4 cells (3 × 106) were treated with 2 M, 5 M
and 10 M concentrations of DQQ for 24 h. Cytosolic
fractions were prepared by selective plasma membrane
permeabilization with digitonin [23]. Brieﬂy, 2 × 106
cells were lysed for 1–2 min  in lysis buffer contain-
ing 75 mM NaCl, 8 mM Na2HPO4, 1 mM NaH2PO4, 1 mM
EDTA, 350 g/ml digitonin and 1% (v/v) eukaryotic pro-
tease  inhibitor cocktail. The lysates were centrifuged at
12,000  × g for 1 min, and the supernatant collected as
cytosolic fraction. Residual pellet was  lysed with buffer
composed of 150 mM NaCl, 50 mM Tris (pH 8.0), 5 mM
EDTA,  1% (vol/vol) Nonidet p-40, 1 mM phenylmethylsul-
fonyl ﬂuoride, 20 g/ml aprotinin, and 25 g/ml leupeptin
for 30 min  at 4 ◦C. After centrifugation at 12,000 × g for
10  min  at 4 ◦C, cell lysates were transferred to fresh tubes
and  stored as mitochondrial fraction.
2.14. Western blot analysisEqual  amount of protein (30–70 g) were subjected
to SDS-PAGE and then electro transferred to PVDF mem-
brane  for 100 min  at 4 ◦C at 100 V. Nonspeciﬁc binding was
blocked  by incubation with 5% non-fat milk or 3% BSA in
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ris-buffered saline containing 0.1% Tween-20 (TBST), for
 h at room temperature. The membranes were incubated
ith respective primary antibodies for 4 h and washed
wice with TBST. After that, blots were incubated with
orseradish peroxidase conjugated secondary antibodies
or  1 h and washed three times with TBST. Blots were incu-
ated  with ECL plus reagent and signal captured by using
yperﬁlm (GE Healthcare) [24].
.15. Small interfering RNA (siRNA)
Human cytochrome c and beclin 1 speciﬁc siRNA were
ransfected into MOLT-4 cells by using manufacturer pro-
ocol.  Brieﬂy, 2 × 105 MOLT-4 cells were seeded in six
ell plates and incubated in transfection media containing
qual amounts of transfection reagent and siRNA for 8 h.
omplete  media was added to cells different experiments
ere performed within 72 h of transfection. Knocking
own of the expression of the respective proteins was
hecked by western blotting.
.16.  mTOR kinase assay
mTOR  inhibition of DQQ was found out by using K-
ISATM mTOR kit from Calbiochem (no. CBA055). It is
n  ELISA-based assay that utilizes a p70S6K-GST fusion
rotein as a speciﬁc mTOR substrate. The assay was car-
ied  out according to the manufacturer’s protocol. Brieﬂy,
00  l of recombinant p70S6K-GST fusion protein was
re-incubated at room temperature in the glutathione
oated 96-well plate for 1 h after that a mixture of 49 l
f  ice-chilled mTOR kinase and 1 l of test compounds
r DMSO was added. The reaction was initiated by the
ddition of 50 l of mTOR kinase assay buffer containing
00 M ATP and 1 M DTT. The plate was treated ﬁrst
ith 100 l of anti-p70S6K-T389 for 1 h and then with
00  l of HRP-conjugated antibody for 1 h to detect the
389-phosphorylated p70S6K. Absorbance was measured
t  450 nm and 595 nm using microplate spectrophotome-
er. The IC50 values were calculated by analysis non linear
egression with variable slope by using GraphPad Prism-5
oftware.
.17.  Statistical analysis
Data  expressed as mean ± SD or a representative of one
f  three similar experiments unless otherwise indicated.
omparisons were made between control and treated
roups or the entire intra group using one way  and two
ays  ANOVA with post Bonferroni test through GraphPad
rism 5.00.288 statistical analysis software by GraphPad
oftware, Inc. p -values * <0.01 were considered signiﬁcant
hen compared to untreated control or respective DQQ
reated  cells.
.  Results
.1. DQQ inhibited cell proliferation in MOLT4 and K562
ells
Cells  treated with different doses of DQQ for different
ime frames, displayed inhibited viability in a dose and timerts 1 (2014) 1013–1025 1017
dependent  manner (Fig. 1B and C). The IC50 of DQQ against
K562  and MOLT-4 was  determined at different time points
which  come out to be 24 M,  19 M,  7 M and 4 M in 6 h,
12  h, 24 h and 48 h, respectively, in MOLT-4 cells (Fig. 1B
and  C), while in case of K562 cells the IC50 values were
62  M,  36 M,  16 M and 12 M in 6 h, 12 h, 24 h and 48 h,
respectively (Fig. 1B and C). The IC50 values of DQQ in K562
cells  were comparatively higher than observed in MOLT-
4  cells. Thus, the MOLT-4 cell line was  taken for further
mechanistic studies.
3.2.  DQQ induced apoptosis in MOLT-4 cells
Apoptosis was  one of the modes of leukemic cell
death induced by DQQ, which was further conﬁrmed
by a battery of apoptosis assays Hoechst and annexin-V
staining, cell cycle and mitochondrial potential analysis.
Phase contrast and nuclear microscopy results revealed
that DQQ substantially induced apoptosis in MOLT-4 cells
in  a dose dependent manner (Fig. 2A and B). Nuclei of
untreated MOLT-4 cells appeared round in shape, while
treatment with DQQ resulted in nuclear condensation
and the formation of apoptotic bodies. The morpholog-
ical changes were accompanied by an increase in the
number of scattered apoptotic bodies, indicated by white
arrows  (Fig. 2B). AnnexinV/PI staining is widely used to
distinguish between apoptosis and necrotic population.
The results of AnnexinV/PI staining suggested that the
cell  death induced by DQQ was of apoptotic nature as
the  amount of population positive for PI was negligible.
The percentage of apoptotic population was  signiﬁcantly
higher (10–20 times) in DQQ treated MOLT-4 cells as
compared to untreated control (Fig. 2C). Apoptosis was
further  conﬁrmed by cell cycle analysis using propidium
iodide staining. Measurement of DNA content makes it
possible  to identify apoptotic cells and cell cycle phase
speciﬁcity. The results revealed that DQQ substantially
induced 3–10 times increase in hypo-diploid sub-G0 DNA
fraction  (apoptotic, <2nDNA) in cell cycle phase distri-
bution (Fig. 2D). The sub-G0 fraction (apoptotic) was
7%  in control cells, which increased up to 69% after
10 M concentrations of DQQ treatment in MOLT-4 cells
(Fig.  2D). The early event which was associated with DQQ
induced apoptosis was found to be loss of mitochondrial
membrane potential ( m). Mitochondrial membrane
potential loss is one of the important and commonly
occurring events in apoptosis. DQQ signiﬁcantly enhanced
the  same in a dose-dependent manner in MOLT-4 cells
(Fig.  2E). The MMP  loss was  increased from 6% to 63%
in  untreated and DQQ treated MOLT-4 cells, respectively
(Fig. 2E).
3.3.  DQQ induced apoptosis via both extrinsic and
intrinsic pathways
We  investigate the pathway of apoptosis induced by
DQQ  in MOLT-4 cells by monitoring the level of differ-
ent mitochondrial proteins and caspases. Upregulation of
Bax  and down regulation of Bcl-2 have long been asso-
ciated with the activation of apoptosis. DQQ inhibit the
mitochondrial anti-apoptotic protein Bcl-2 and induce the
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Fig. 2. Effect of DQQ on the apoptosis and early events associated with it. (A) and (B) Effect of HMC  on cellular and nuclear morphology. MOLT-4 cells were
seeded  in a 12 well plate, treated with indicated concentrations of DQQ for 24 and visualized for cellular and nuclear morphology as described in Section 2.
Condensed  nuclei and the apoptotic bodies are indicated by white arrows. Data are representative of one of three similar experiments. (C) Flow cytometric
analysis  of apoptosis and necrosis induced by DQQ using Annexin V-FITC and PI double staining. Other conditions were described in Section 2 and data is
representative  of one of three similar experiments. (D) Cell cycle phase distribution of DQQ treated MOLT-4 cell lines were analyzed by staining of cells
with  PI for 30 min  and DNA ﬂuorescence were determined ﬂowcytometrically (FACS Calibur, BD Biosciences) as described in Section 2. Data were analyzed
by  Modﬁt software (Verity Software House Inc., Topsham, ME)  for the proportions of different cell cycle phases. The fraction of cells from apoptosis, G1,
S  and G2 phases analyzed from FL2-A vs cell counts are shown in %. Data are representative of one of three similar experiments. (E) DQQ induced loss
of  mitochondrial membrane potential ( m). MOLT-4 cells were incubated with the indicated doses of DQQ for 24 h. Thereafter, cells were stained with
Rhodamine-123  (200 nM), added 40 min  before experiment termination and analyzed in FL-1 channel of ﬂow cytometer. Data are representative of one of
three  similar experiments.
translocation of Bax from cytosol to mitochondria and
simultaneously released cytochrome c from mitochondria
to  cytosol, which was associated with mitochondrial mem-
brane  potential loss (Figs. 2E and 3A). DQQ drastically
reduce the Bcl-2/Bax ratio in MOLT-4 cells from 10 to 0.2
levels  (Fig. 3C). The Bcl-2/Bax ratio has also been found
to  play key role in the activation of caspase-3 [25]. Cas-
pase  activation is one of the basic events in the process of
apoptosis. DQQ signiﬁcantly induce caspase-3 and -8 lev-
els  (4 times) in MOLT-4 cells in a dose-dependant manner
(Fig.  3B). The caspase activation was further conﬁrmed by
western  blotting against procaspase-3 and procaspase-8
(Fig. 3A). DQQ signiﬁcantly alter mitochondrial apoptotic
proteins and caspase-8 level that interlinks both the apop-
totic  pathway and ﬁnally lead to caspase-3 activation and
PARP-1  cleavage (Fig. 3A–C). The above data suggest thatDQQ  induced apoptosis in MOLT-4 cells via both extrinsic
and  intrinsic pathways.
3.4.  DQQ inhibited AKT/mTOR signaling pathway
The role of AKT/mTOR has long been contemplated in
the  regulation of autophagy and apoptosis. This pathway
has  been reported as a negative regulator of both apopto-
sis  and autophagy [26]. Therefore, it was evident to see
the  effect of DQQ on the proteins of AKT/mTOR pathway.
Western blot analysis of different proteins of this pathway
revealed that DQQ signiﬁcantly hampered the expression
of  pAKT, pmTOR and its substrate pP70S6K in MOLT-4
cells (Fig. 3A). The most signiﬁcant inhibitory effect was
on  pmTOR followed by its substrate p70S6K (Fig. 3A). The
mTOR  kinase IC50 value of DQQ was  found to be 6 nM in a
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ell free Elisa assay (Fig. 3D). DQQ was found to be a strong
TOR  inhibitor and its expression almost negligible, even
t  low concentration (2 M).
.5. DQQ induced autophagy in MOLT-4 cells
The autophagy induction in cells treated with DQQ was
nalyzed by acridine orange staining. The results of acri-
ine  orange staining revealed that it induced formation
f  acidic vacuolar organelles (AVO) in MOLT-4 cells, while
he  number of AVO was negligible in control cells. The
umber of AVO increased with increasing doses of DQQ
Fig.  4A). Furthermore, western blot analysis of key pro-
eins  of autophagy such as beclin1, ATG7, ATG5 and LC3-II
evealed that DQQ signiﬁcantly increased their expres-
ion in a dose dependent manner (Fig. 4A). The autophagy
nduction was further conﬁrmed by LC3 immunoﬂuores-
ence. The results indicated that DQQ treatment induced
ose dependent increase in LC3 ﬂuorescence in MOLT-4
ells (Fig. 4B).
.6.  DQQ induce caspase dependent apoptosis and
utophagy
As DQQ induced activation of caspase in MOLT-4 cells
nd  caspase have a signiﬁcant role in the induction of both
utophagy and apoptosis [11]. We  found that addition of
an  speciﬁc caspase inhibitor Z-VAD-fmk to DQQ treated
OLT-4 cells signiﬁcantly reversed the inhibition of cell
iability  effect (Fig. 5A). The viability was reversed from
5%  to 87% and from 41% to 60% in Z-V-FMK pretreated
amples treated with 5 M and 10 M of DQQ, respectively
Fig. 5A). Furthermore, effect of Z-V-FMK pretreatment
as observed in the expression of important proteins of
utophagy and apoptosis. The expression of beclin1, ATG7,
aspase  3 and PARP and was reversed in Z-V-FMK pre-
reated samples (Fig. 5B). All these data suggested that
QQ  induce caspase arbitrated apoptosis and autophagy
n  MOLT-4 cells.
.7.  DQQ induce cytochrome c mediated autophagy and
poptosis
Earlier  experiments suggested that DQQ induced
ranslocation of cytochrome c and hence activation of apo-
tosis.  Role of cytochrome c in apoptosis induction and
utophagy inhibition was  very well known [12]. Contra-
ictory to existing reports, we were ﬁrst time reporting
he negative feedback regulation of cytochrome c medi-
ted  induction of autophagy. The cell viability data revealed
 dramatic effect of cytochrome c silencing on reversal
f cell death induced by DQQ. The viability was reversed
rom 60% to 98% in untreated and DQQ treated (5 M)
OLT-4 cells, transfected with cytochrome c siRNA, respec-
ively  (Fig. 6A). A similar kind of reversal was observed in
ells  transfected with cytochrome c siRNA and treated with
0  M of DQQ (Fig. 6A). Furthermore, the expression of
utophagic protein LC3-II was reversed in the cytochrome c
ilenced  cell, suggesting the undeviating proportional role
f  cytochrome c on autophagy induction (Fig. 6B). The effect
f  cytochrome c silencing on MMP  loss was also assessedrts 1 (2014) 1013–1025 1019
and  results of the same revealed that cytochrome c silenc-
ing  reversed the MMP  loss induced by DQQ (Fig. 6C). The
MMP  loss was reversed from 58% to 14% and from 66% to
37%  in cells treated with 5 M and 10 M of DQQ, respec-
tively (Fig. 6C). The autophagy inhibition by cytochrome
c silencing was also conﬁrmed by acridine orange stain-
ing.  The results of acridine orange staining showed that
autophagy induced by DQQ in normal MOLT-4 cells was
signiﬁcantly reversed in MOLT-4 cells transfected with
cytochrome c siRNA (Fig. 6D). Collectively, all these data
suggested that cytochrome c is required for both DQQ
induced apoptosis and autophagy in MOLT-4 cells.
3.8.  Beclin1 silencing partially reversed the cell death
induced by DQQ
The  results of the previous experiments showed that
apoptosis inhibition through Z-V-FMK and cytochrome c
silencing  also reversed the autophagy induced by DQQ. So,
it  was evident to check the effect of autophagy inhibition
on  cell viability and apoptosis. Beclin1 silencing through
siRNA partially reversed the effect of DQQ on cell viabil-
ity  inhibition, which was not as much signiﬁcant as by
cytochrome c inhibition (Fig. 7A). The Cell viability inhi-
bition  was reversed from 60% to 82% and from 45% to 65%
in  beclin1 silenced cells treated with 5 M and 10 M of
DQQ,  respectively (Fig. 7A). Furthermore, the PARP-1 cleav-
age  was also partially reversed in beclin1 silenced MOLT-4
cells  treated with similar concentrations of DQQ (Fig. 7B).
Acridine  orange staining revealed that autophagy induced
by  DQQ was dramatically reversed in beclin 1 silenced sam-
ple  (Fig. 7C). The results indicated the partial role of beclin1
on  apoptosis and cell death induced by DQQ in MOLT-4
cells.
4.  Discussion
Apoptosis and autophagy are referred to as pro-
grammed cell death type 1 and type 2, respectively. These
are  two important processes that control the turnover of
organelles and proteins within the organism. Many stress-
ors  and chemical agents have been found to sequentially
elicit autophagy and apoptosis within the same cell [27].
Autophagy and apoptosis have been shown to have a
complex relation with each other, as under certain circum-
stances autophagy protects the cell from death by adapting
certain mechanism and thus inhibit apoptotic cell death.
However, in certain cases it can lead the cell to death and
constitute the alternate death pathway [27]. In some case
autophagy may  lead to apoptosis and both acts together to
induce  programmed cell death [28]. In this study, we have
tried  to study the crosstalk between autophagy and apopto-
sis.  We  for the ﬁrst time report the cytochrome c mediated
induction of autophagy in MOLT-4 cells. Our preliminary
experiments showed that a novel quinazolinone deriva-
tive  2,3-dihydro-2-(quinoline-5-yl) quinazolin-4(1H)-one
[DQQ], substantially induced cell death in MOLT-4 cells.
Furthermore, the mechanistic studies discovered that the
cell  death induced by DQQ in MOLT-4 cells was autophagic
as  well as apoptotic in nature. The apoptosis and autophagy
induction was  conﬁrmed by an array of experiments like
1020 S. Kumar et al. / Toxicology Reports 1 (2014) 1013–1025
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Fig. 4. DQQ induced autophagy in MOLT-4 cells. (A) Autophagy detection through acridine orange staining. Cells were seeded in a six well plate and treated
with  the indicated doses of DQQ for 24 h. Acridine orange (AO) was added 15 min  before the termination of the experiment. After completion of treatment
period  cells were collected washed once and observed under ﬂuorescence microscope. (B) LC3 immunoﬂuorescence staining for autophagy detection. Cells
were seeded in a 12 well plate and treated with different concentrations of DQQ for 24 h. Cells were processed for immunoﬂuorescence against LC3 as
described  in Section 2. DAPI was used as nuclear staining dye and both the images were merged on same magniﬁcation. (C) Effect of DQQ on the key
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autophagic  proteins. MOLT-4 cells were treated with DQQ at the indicate
qual  amount of proteins (50–70 g) were separated by SDS-PAGE and w
ata  were representative of one of three similar experiments.
ellular and nuclear microscopy, Annexin-V binding, loss of
MP,  cell cycle analysis, immunoﬂuorescence and immu-
oexpression of key apoptotic and autophagic proteins.
NA damage is considered as the sign of apoptosis [29],
QQ  potentially induced DNA damage, which was con-
rmed  through Hoechst staining. The DNA damage was
ig. 3. Inﬂuence of DQQ on the expression of important proteins involved in the initi
ith  the indicated doses of DQQ for 24 h. A Protein lysates were prepared and ele
nternal  controls to represent the same amount of proteins applied for SDS-PAGE
espective  cell fractions. Data are representative of one of three similar experimen
ctivities  were determined by ﬂuorimetric method in the cell lysates by using BD
imilar  experiments and p values: * <0.01 was  considered to be signiﬁcant when 
ax  of MOLT-4 cells. The relative density of each band was  measured using imag
nalysis  was  done by using bonferroni method and p value <0.01 was  considere
QQ  was found out as per the manufacturer’s protocol provided in K-LISATM mTO
nalysis  non linear regression with variable slope by using GraphPad Prism-5 sofntrations for 24 h time period, lysates were prepared using RIPA buffer,
lot as described in Section 2. -Actin was used as an internal control and
further conﬁrmed by cell cycle analysis using PI staining
and DQQ potentially induced G0/G1 phase of cell cycle,
which was directly correlated to apoptosis [30]. Further-
more, DQQ mediated apoptosis induction was  conﬁrmed
by  annexin V/PI stating and the results of the same sug-
gested dose dependent increase in apoptosis.
ation of apoptosis and AKT/mTOR signaling. (A) MOLT-4 cells were treated
ctrophoresis as described in Section 2. COX IV and -actin were used as
. Speciﬁc antibodies were used for detection of the indicated proteins in
ts. (B) DQQ induces caspase-8 and -3 levels in MOLT-4 cells. The caspases
 ApoAlert caspase ﬂuorescent assay kits. Data are mean ± S.D. from three
compared with untreated control. (C) Inﬂuence of DQQ on the Bcl-2 and
e j software. Data are mean ± SD of three similar experiments; statistical
d to be signiﬁcant. (D) DQQ inhibits mTOR kinase. mTOR inhibition by
R kit from Calbiochem (no. CBA055). The IC50 values were calculated by
tware.
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Fig. 5. Effect of caspase inhibitors on DQQ induces apoptosis and autophagy. (A) MOLT-4 cells were seeded in 96 well plates and pretreated with pan speciﬁc
caspase  inhibitor, Z-VAD-FMK (30 M)  30 min  before the addition of DQQ. MTT  dye was added 3 h before the termination of the experiment. Cell viability
was  calculated as described in Section 2. Data are mean ± S.D. from three similar experiments and p values:*<0.001 was  considered to be signiﬁcant when
compared  with DQQ. (B) DQQ induces caspase dependent apoptosis and autophagy. MOLT-4 cells were treated indicated concentrations of DQQ for the 24 h
time period in the presence and absence of caspases inhibitors (30 M)  Z-VAD-FMK. Cells were collected and lysed in RIPA buffer and equal amount of protein
samples  were loaded on SDS PAGE for western blot analysis as described in Section 2. -Actin was used as an internal control and equal amount of proteins
applied  for SDS-PAGE. Speciﬁc antibodies were used for detection of the indicated proteins. Data are representative of one of three similar experiments.
Fig. 6. siRNA mediated silencing of cytochrome c reversed the apoptosis as well as autophagy induced by DQQ in MOLT-4 cells. (A) Cells were transfected with
cytochrome  c siRNA as described in Section 2. Cells were seeded in 96 well plates and treated with different concentrations of DQQ for 48 h. Cells were
incubated  with MTT solution and optical density of formazon crystals was measured as described in Section 2. Data are mean ± S.D. from three similar
experiments  and p values: * <0.001 was considered to be signiﬁcant when compared with DQQ. (B) Effect of cytochrome c silencing on DQQ induce apoptosis
and  autophagy. Transfected and non transfected cells were seeded in six well plates and incubated with the indicated doses of DQQ for 24 h. Cells were lysed
in  RIPA buffer and immunoblotting of the indicated proteins were done as described in Section 2. Data are representative of one of three similar experiments.
(C)  Effect of cytochrome c silencing on DQQ induce loss of mitochondrial membrane potential. Normal and cytochrome c siRNA transfected MOLT-4 cells
were  treated with different doses of DQQ for 24 h. Cells were stained with Rhodamine-123 (200 nM), added 40 min  before experiment termination and
analyzed  in FL-1 channel of ﬂow cytometer. Data are representative of one of three similar experiments. (D) Cytochrome c siRNA reversed the autophagy
induced  by DQQ. Cells were transfected with cytochrome c siRNA as described in Section 2. Transfected and non transfected cells were treated with indicated
doses  of DQQ. Acridine orange was added 15 min  prior to termination of the experiment and ﬂuorescence was observed as described in Section 2.
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Fig. 7. Beclin1 silencing partially reversed autophagy and apoptosis induced by DQQ. MOLT-4 cells were transfected with beclin1 siRNA as described in Section
2. Cells were seeded in 96 well plates and treated with different concentrations of DQQ for 48 h and cell viability was  measured as described in Section 2.
Data  are mean ± S.D. from three similar experiments and p values: * <0.001 was considered to be signiﬁcant when compared with DQQ. (B) Beclin1 siRNA
transfected  and non-transfected MOLT-4 cells were treated with 5 M and 10 M concentration of DQQ for 24 h. Cells were lysed in RIPA buffer western
blot  of the indicated proteins were done as described in Section 2. Data are representative of one of three similar experiments. (C) Beclin1 knockdown
reversed  the autophagy as observed by acridine orange staining. siRNA transfected and non transfected cells were treated with indicated doses of DQQ.
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Apoptosis can be triggered by various stimuli by extrin-
ic  or intrinsic pathways. Extrinsic pathway involved the
ignal  transduction from death receptors and caspase-8
hile the intrinsic apoptotic pathway involves mito-
hondrial apoptotic proteins (Bcl-2, Cyt c, Bax), which
re  activated downstream of mitochondrial pro-apoptotic
vents [18]. The early event which was responsible for
QQ  induces apoptosis, found to be loss of mitochondrial
otential (Fig. 2E). DQQ signiﬁcantly triggers mitochondrial
otential loss in MOLT-4 cells that indicating the involve-
ent  of mitochondrial PTP in the release of pro apoptotic
roteins. We  further investigated the role of members of
he  Bcl-2 family of proteins from mitochondria. Bcl-2 fam-
ly  proteins play both pro-apoptotic and anti-apoptotic role
n  cancer cells. The normally Bcl-2 level is much higher
n  the cancer cell. We  observed a drastic reduction in
cl-2  expression after the treatment of MOLT-4 cells to
QQ  that might be linked with the loss of mitochondrial
embrane potential. Bcl-2 inhibition by DQQ alter thene orange ﬂuorescence was measured under ﬂuorescence microscope as
symmetry of mitochondria, which causes the opening of
the  mitochondrial transformable pore and brings about
Bax  translocation from cytosol to mitochondria and con-
sequent  release of small molecules like cytochrome c from
mitochondria to cytosol. DQQ drastically decreased the Bcl-
2/Bax  ratio in MOLT-4 cells in a concentration dependent
manner in 24 h time period (Fig. 3C). Translocation of these
proteins  impairs mitochondrial functions and brings the
cells  to a “point of no return” to enter apoptosis via cas-
pases  activation. Caspase activation is solely regulated by
the  mitochondrial release of apoptotic protease activat-
ing  factor-1 (Apaf-1) and cytochrome c, which is a part
of  the mitochondrial dependant apoptosis pathway [31].
Translocation of cytochrome c from mitochondria to cyto-
sol  is considered as one of the main events of mitochondrial
dysfunction and subsequent apoptosis; it is also associated
with  immediate exposure of phosphatidylserine exposure.
In  light of earlier experiments that demonstrated induc-
tion  of MMP  loss and exposure of phosphatidylserine by
gy Repo1024 S. Kumar et al. / Toxicolo
DQQ, we decided to check the cytochrome c transloca-
tion and found that it signiﬁcantly induced cytochrome c
release  from mitochondria that activate caspase-3 (Fig. 3A
and  B). The elevated level of caspase-3 could utilize poly-
ADP  Ribose polymerase (PARP, 116 kDa), a DNA repair
enzyme as its substrate. As a result a cleaved product
(85 kDa) of PARP was observed in our study. Subsequently,
DQQ treatments also induce caspase-8, which was part of
the  extrinsic apoptosis pathway (Fig. 3A and B). So these
ﬁndings suggest that DQQ caused induction of apoptosis
through both intrinsic and extrinsic apoptotic pathways in
human  leukemia MOLT-4 cells.
We have also found DQQ as a potent inducer of
autophagy in MOLT-4 cells. The autophagy induction was
conﬁrmed  by acridine orange staining, LC3 immunoﬂuo-
rescence and western blot analysis. PI3K/AKT signaling
pathway is one of the important targets in cancer therapy
and  has been found to be negatively associated with both
autophagy and apoptosis [26]. DQQ signiﬁcantly inhibited
the  expression of major proteins of this pathway suggesting
the  role of PI3K/AKT pathway in autophagy and apoptosis
induced by DQQ in MOLT-4 cells.
Caspases have been found to have a regulatory role on
both  apoptosis and autophagy [11] and DQQ was inducing
caspases activation; this pretext led us to check the role
of  caspases in autophagy and apoptosis regulation. Inter-
estingly, we have found that apoptotic and autophagic cell
death  induced by DQQ was caspase-dependent. A univer-
sal  caspase inhibitor, Z-VAD-FMK, revert back the entire
key  event associated with DQQ mediated MOLT-4 cell
death.  Caspase inhibitor reversed cell growth inhibition
and key protein expression of PARP-1, caspase-3, beclin1
and  ATG7, which were induced by DQQ (Fig. 5A and B).
These  ﬁndings put forward the key role of caspases in the
induction of apoptosis and autophagy. Therefore, we can
say  that DQQ induce caspase dependant autophagy and
intrinsic  and extrinsic apoptosis in human leukemic MOLT-
4  cells.
Furthermore, cytochrome c inhibition through siRNA,
very  signiﬁcantly blocked the activity of DQQ in terms of
viability,  apoptosis and autophagy (Fig. 6A–C). However,
we did not get such type of signiﬁcant reversal effect by
silencing the MOLT-4 cells through beclin1 siRNA (Fig. 7A
and  B). The MOLT-4 cell viability reversal effect of DQQ
via  cytochrome c siRNA was much higher than the caspase
inhibitor and beclin1 siRNA. Interestingly, our study
ﬁrst time portrays the negative feedback control role of
cytochrome c in the activation of autophagy. Thousands of
publications  revealed the role of cytochrome c in apoptosis
induction, but none has described its role in autophagy
induction, although there are evidences suggesting the
inhibitory role of cytochrome c on autophagy [12]. Fur-
thermore, the crosstalk between autophagy and apoptosis
was  conﬁrmed by silencing of beclin1 through siRNA. The
results  of the experiments revealed that beclin1 inhibition
partially reversed the viability and the PARP-1 cleavage
inhibition induced by DQQ; indicating the partial role of
beclin1  in apoptosis. The experiment also conﬁrmed the
notion  that autophagy and apoptosis induced by DQQ
in  MOLT-4 cells were interdependent. Much of the work
has  been done in the ﬁeld of apoptosis and autophagy;rts 1 (2014) 1013–1025
however the relation between the two  is still controversial
and unexplored to some extent.
In conclusion, the present study brieﬂy describes the
crosstalk between autophagy and apoptosis induced by a
novel  quinazolinone derivative, DQQ, in human leukemia
MOLT-4 cells. It induces extrinsic and intrinsic apoptosis,
conﬁrmed by apoptotic bodies’ formation, PS exposure,
enhance sub-G0 population and induction of various apop-
totic  proteins like Bcl-2/Bax, PARP and caspase. We  for
the  ﬁrst time elucidated the negative feedback role of
cytochrome c in autophagy induction. Hence, our discov-
ery  of this novel mechanism not only further insight the
interdependent role of apoptosis and autophagy, but also
disclose  the clinical signiﬁcance of agent like DQQ, that
simultaneously induce apoptosis and autophagy.
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